Mr Nathan Allen Crowell, LCSW, PIP | |
517 18th St N, Bessemer, AL 35020-4843 | |
(205) 386-0354 | |
(205) 592-0060 |
Full Name | Mr Nathan Allen Crowell |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 517 18th St N, Bessemer, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720252992 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mr Nathan Allen Crowell, LCSW, PIP Po Box 55034, Birmingham, AL 35255-5034 Ph: (205) 386-0354 | Mr Nathan Allen Crowell, LCSW, PIP 517 18th St N, Bessemer, AL 35020-4843 Ph: (205) 386-0354 |
News Archive
Scientists are reporting the development and successful initial testing of a new form of methotrexate the mainstay anticancer drug designed to be given as nose drops rather than injected. It shows promise as a more effective treatment for brain cancer, they say. The report appears in ACS' Molecular Pharmaceutics, a bi-monthly journal.
A new advance in biomedical research at the University of Leicester could have potential in the future to assist with tackling diseases and conditions associated with ageing - as well as in treating cancer.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
National Mentor Holdings, Inc. (the "Company") today announced its financial results for the fourth quarter and fiscal year ended September 30, 2009.
› Verified 2 days ago